Skip to main content
LXRX logo

LXRX · Lexicon Pharmaceuticals, Inc. · Analyst Estimates

Track LXRX — free
$1.88 -0.01 (-0.27%) At close · Sep 30
Market Cap
$798.70M
Shares
444.96M
Volume · Sep 30 1.74M Avg daily vol (3M) 2.96M

Analyst Estimates

Compare analyst forecasts for Lexicon Pharmaceuticals, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-30 10:07 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.18
-0.16632
-0.15
—
-0.15866
-0.15866
-0.15866
-0.15866
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
2
2
0
0
Revenue
USD
Publication date not stated
31794000
37165550
44300000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.27242
-0.1906
-0.11
—
-0.20628
-0.20628
-0.20628
-0.20628
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
0
16934370
58500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.06
-0.0529
-0.04
—
-0.05955
-0.05955
-0.05955
-0.05955
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
0
4144730
10900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.04
-0.03607
-0.03
—
-0.0469
-0.0469
-0.0469
-0.0469
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
2
2
Revenue
USD
Publication date not stated
749000
11217320
21700000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —
Key facts CIK 1062822 CUSIP 528872302 13F (30d) 4 filings 4 filers Visit website Investor relations